Article
AT1 mutations and risk of atrial fibrillation based on genotypes from 71,000 individuals from the general population.
British journal of clinical pharmacology - 1 Jul 2013
Marott Sarah C W, Nordestgaard Børge G, Jensen Gorm B, Tybjaerg-Hansen Anne, Benn Marianne
Abstract excerpt
AIMS: Activation of the angiotensin II type 1 (AT1 ) receptor has been shown to mediate the structural and electrical remodelling of the atrial myocardium associated with atrial fibrillation. We hypothesized that AT1 genotypic variation is associated with atrial fibrillation or diseases predisposing to atrial fibrillation, such as hypertension, heart failure, ischaemic heart disease and myocardial infarction, in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
